Search

everythinglearnresearchcommunity

for

Search:↓

Researchers identified promising inhibitors for the BRD4 protein, including finasteride and amentoflavone.

Early diagnosis and combination therapy, especially with finasteride and dutasteride, are key to managing Frontal Fibrosing Alopecia effectively.

Finasteride effectively treats hair loss and enlarged prostate in men, with mild side effects.

Marine sponges from Tabuhan Island can inhibit enzymes linked to Alzheimer's and hair loss.

Blocking CYP17A1 enzyme may help improve certain brain function issues related to dopamine.

Chemoprevention can significantly lower cancer risks and needs more research and collaboration.

Early surgery reduces seizure risk in drug-resistant epilepsy; testosterone to DHT conversion doesn't affect muscle anabolism; veterans with PTSD likely to have riskier opioid use; bevacizumab helps in hereditary bleeding disorder.

Men taking dutasteride may have a higher risk of age-related macular degeneration.

The authors suggest that 5-α-reductase inhibitors, like dutasteride, are effective in treating frontal fibrosing alopecia and should be the first-line treatment, with other options for severe cases. They also recommend further research on Janus kinase inhibitors.

Cannabinoid and steroid-based drugs could be new treatments for Tourette syndrome, but more research is needed to confirm their effectiveness and safety.

These new skin treatments are safer and more effective with minimal side effects.

Benzo[c]quinolizin-3-ones are effective nonsteroidal inhibitors of human steroid 5α-reductase 1.

A new compound effectively inhibits human 5α-reductase 1.

In 2024, the FDA approved 27 innovative small-molecule drugs, with many offering significant treatment improvements.

A man's low testosterone and related symptoms improved after he stopped taking hair loss drugs.

Pill organizers and cutters can help with taking medication regularly but may affect the medication's effectiveness and safety.

Scientists made a carbon-14 labeled version of a drug with a 48% yield and over 99% purity.

5α-reductase inhibitors lower overall prostate cancer risk but not high-grade cancer risk; longer-term screening and new treatments show promise.

The correction states that the label change for Finasteride was in 2012, leading to more reports of side effects from non-healthcare people.

Higher SRD5A2 expression predicts better response to finasteride in treating urinary symptoms.

Newer retinoid drugs are effective for skin conditions but have significant side effects.

Using 5α-reductase inhibitors for hair loss can cause lasting sexual, physical, mental, and vascular health issues in men, even after stopping the medication.

Many potential alopecia treatments need more testing to confirm they promote acceptable hair growth with minimal side effects.

Taking 5-α reductase inhibitors for prostate enlargement or hair loss does not significantly raise the risk of erectile dysfunction.

Etifoxine, an anxiety drug, can lessen brain inflammation and cognitive issues in mice, partly by increasing production of protective brain steroids.

Epristeride's metabolism involves key metabolites and proteins, affecting its use in doping tests.

Carbamates may help treat androgen-dependent conditions by changing how certain lipid enzymes are produced.

Reducing 5α-reductase activity helps endometrial cells differentiate, aiding pregnancy.